Opaleye Management Inc. 13D and 13G filings for TRACON Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-31 9:40 pm Purchase | 2020-08-27 | 13G | TRACON Pharmaceuticals, Inc. TCON | Opaleye Management Inc. | 85,917 13.030% | 85,917 (New Position) | Filing |